1.Ryoo SR, Jeong HK, Radnaabazar C, Yoo JJ, Cho HJ, Lee HW, Kim IS, Cheon YH, Ahn YS, Chung SH et al.. (2007) DYRK1A-mediated hyperphosphorylation of Tau. A functional link between Down syndrome and Alzheimer disease.. J Biol Chem, 282 (48):(34850-7). [PMID:17906291]
2.Kimura R, Kamino K, Yamamoto M, Nuripa A, Kida T, Kazui H, Hashimoto R, Tanaka T, Kudo T, Yamagata H et al.. (2007) The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease.. Hum Mol Genet, 16 (1):(15-23). [PMID:17135279]
3.Ferrer I, Barrachina M, Puig B, Martínez de Lagrán M, Martí E, Avila J, Dierssen M. (2005) Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.. Neurobiol Dis, 20 (2):(392-400). [PMID:16242644]
4.Park J, Song WJ, Chung KC. (2009) Function and regulation of Dyrk1A: towards understanding Down syndrome.. Cell Mol Life Sci, 66 (20):(3235-40). [PMID:19685005]
5.Foucourt A, Hédou D, Dubouilh-Benard C, Girard A, Taverne T, Casagrande AS, Désiré L, Leblond B, Besson T. (2014) Design and synthesis of thiazolo[5,4-f]quinazolines as DYRK1A inhibitors, part II.. Molecules, 19 (10):(15411-39). [PMID:25264830]
6.Coutadeur S, Benyamine H, Delalonde L, de Oliveira C, Leblond B, Foucourt A, Besson T, Casagrande AS, Taverne T, Girard A et al.. (2015) A novel DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro.. J Neurochem, 133 (3):(440-51). [PMID:25556849]
Solution Calculators
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
